ROBERT F APPLE Insider Trading $ATRS ANTARES PHARMA, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ROBERT F APPLE.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ROBERT F APPLE. ROBERT F APPLE is Executive Vice President & COO in ANTARES PHARMA, INC. ($ATRS) and President & CEO in ANTARES PHARMA, INC. ($ATRS).

ROBERT F APPLE in ANTARES PHARMA, INC.

Trading Symbol: ATRS
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of ROBERT F APPLE: President & CEO, Executive Vice President & COO
Holdings: 2,563,033 shares
Current Value: $5,638,673
Latest Transaction: Feb 19 2021
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ROBERT F APPLE in ANTARES PHARMA, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 19 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM0.88250,000220,0000
Feb 19 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM2.625,51914,4600
Feb 19 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS5.00241,9601,209,8002,204,7602.4 M to 2.2 M (-9.89 %)
Feb 19 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS5.0117,84489,3982,446,7202.5 M to 2.4 M (-0.72 %)
Feb 19 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS5.00232,1561,160,7802,464,5642.7 M to 2.5 M (-8.61 %)
Feb 19 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM0.88250,000220,0002,696,7202.4 M to 2.7 M (+10.22 %)
Feb 19 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS4.755,51926,2152,446,7202.5 M to 2.4 M (-0.23 %)
Feb 19 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM2.625,51914,4602,452,2392.4 M to 2.5 M (+0.23 %)
Feb 19 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF4.73116,313550,1602,446,7202.6 M to 2.4 M (-4.54 %)
Feb 19 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOGrantA0.00267,87802,563,0332.3 M to 2.6 M (+11.67 %)
Feb 10 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM2.627,27819,0680
Feb 10 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM2.6249,129128,7180
Feb 10 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM2.6233,57487,9640
Feb 10 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS4.757,27834,5712,295,1552.3 M to 2.3 M (-0.32 %)
Feb 10 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM2.627,27819,0682,302,4332.3 M to 2.3 M (+0.32 %)
Feb 10 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS4.7549,129233,3632,295,1552.3 M to 2.3 M (-2.10 %)
Feb 10 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM2.6249,129128,7182,344,2842.3 M to 2.3 M (+2.14 %)
Feb 10 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS4.7533,574159,4772,295,1552.3 M to 2.3 M (-1.44 %)
Feb 10 2021ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM2.6233,57487,9642,328,7292.3 M to 2.3 M (+1.46 %)
Jun 15 2020ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseA2.73776,6172,120,164776,617
Jun 15 2020ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF2.7840,892113,6802,295,1552.3 M to 2.3 M (-1.75 %)
Jun 15 2020ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOGrantA2.73402,9301,099,9992,336,0471.9 M to 2.3 M (+20.84 %)
Jun 09 2020ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF3.1344,223138,4181,933,1172 M to 1.9 M (-2.24 %)
Jun 09 2020ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF3.1248,936152,6801,977,3402 M to 2 M (-2.42 %)
Feb 21 2020ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF3.5390,397319,1012,026,2762.1 M to 2 M (-4.27 %)
Feb 21 2020ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOGrantA0.00210,78202,116,6731.9 M to 2.1 M (+11.06 %)
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM3.9658,524231,7550
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM3.961,0003,9600
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM2.94110,000323,4000
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM1.6697,000161,0200
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM1.52100,000152,0000
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS4.7658,524278,3581,905,8912 M to 1.9 M (-2.98 %)
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM3.9658,524231,7551,964,4151.9 M to 2 M (+3.07 %)
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS4.751,0004,7501,905,8911.9 M to 1.9 M (-0.05 %)
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM3.961,0003,9601,906,8911.9 M to 1.9 M (+0.05 %)
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS4.58110,000503,4261,905,8912 M to 1.9 M (-5.46 %)
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM2.94110,000323,4002,015,8911.9 M to 2 M (+5.77 %)
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS4.6297,000448,4121,905,8912 M to 1.9 M (-4.84 %)
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM1.6697,000161,0202,002,8911.9 M to 2 M (+5.09 %)
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS4.68100,000467,8301,905,8912 M to 1.9 M (-4.99 %)
Dec 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM1.52100,000152,0002,005,8911.9 M to 2 M (+5.25 %)
Nov 13 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM1.10100,000110,0000
Nov 13 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF3.7743,445163,7881,905,8911.9 M to 1.9 M (-2.23 %)
Nov 13 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM1.10100,000110,0001,949,3361.8 M to 1.9 M (+5.41 %)
Jun 14 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseA2.92567,4231,656,875567,423
Jun 14 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOGrantA2.92282,534824,9991,849,3361.6 M to 1.8 M (+18.03 %)
Jun 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF2.8144,225124,2721,566,8021.6 M to 1.6 M (-2.75 %)
Jun 11 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF2.8148,936137,5101,611,0271.7 M to 1.6 M (-2.95 %)
Jun 04 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF2.7952,559146,6401,659,9631.7 M to 1.7 M (-3.07 %)
Feb 22 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF3.2072,245231,1841,712,5221.8 M to 1.7 M (-4.05 %)
Feb 22 2019ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOGrantA0.00254,20501,784,7671.5 M to 1.8 M (+16.61 %)
Aug 23 2018ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM0.4743,00020,2100
Aug 23 2018ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS3.7543,000161,2501,530,5621.6 M to 1.5 M (-2.73 %)
Aug 23 2018ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM0.4743,00020,2101,573,5621.5 M to 1.6 M (+2.81 %)
Jun 11 2018ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseA2.70591,5101,597,077591,510
Jun 11 2018ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOGrantA2.70305,556825,0011,530,5621.2 M to 1.5 M (+24.94 %)
Jun 11 2018ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF2.7032,03186,4841,225,0061.3 M to 1.2 M (-2.55 %)
Jun 05 2018ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF2.6934,40292,5411,257,0371.3 M to 1.3 M (-2.66 %)
May 30 2018ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF2.4313,48032,7561,291,4391.3 M to 1.3 M (-1.03 %)
May 14 2018ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM0.8582,50070,1250
May 14 2018ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF2.5230,05275,7311,304,9191.3 M to 1.3 M (-2.25 %)
May 14 2018ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM0.8582,50070,1251,334,9711.3 M to 1.3 M (+6.59 %)
Jun 09 2017ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseA2.66725,7511,930,498725,751
Jun 09 2017ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOGrantA2.66338,115899,3861,175,6371.5 M to 1.2 M (-22.34 %)
Jun 09 2017ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF2.5738,03497,747837,522875.6 K to 837.5 K (-4.34 %)
Jun 09 2017ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF2.513,3908,509875,556878.9 K to 875.6 K (-0.39 %)
Jun 09 2017ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF2.5114,90337,407878,946893.8 K to 878.9 K (-1.67 %)
Jun 09 2017ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF2.371,7634,178893,849895.6 K to 893.8 K (-0.20 %)
Jun 09 2017ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOGrantA0.005,6120895,612890 K to 895.6 K (+0.63 %)
Apr 05 2017ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM1.653,0004,9500
Apr 05 2017ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM1.6537,00061,0503,000
Apr 05 2017ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS3.003,0009,000890,002893 K to 890 K (-0.34 %)
Apr 05 2017ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM1.653,0004,950893,002890 K to 893 K (+0.34 %)
Apr 05 2017ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOSellS3.0037,000111,070890,002927 K to 890 K (-3.99 %)
Apr 05 2017ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM1.6537,00061,050927,002890 K to 927 K (+4.16 %)
Dec 29 2016ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseM1.2360,00073,8000
Dec 29 2016ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF2.3539,71793,335890,002929.7 K to 890 K (-4.27 %)
Dec 29 2016ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyM1.2360,00073,800929,719869.7 K to 929.7 K (+6.90 %)
Jun 30 2016ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOGrantA1.0511,22311,784869,719858.5 K to 869.7 K (+1.31 %)
Jun 06 2016ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseA1.12773,700866,544773,700
Jun 06 2016ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOGrantA1.12363,150406,728858,496495.3 K to 858.5 K (+73.31 %)
Jun 01 2016ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF0.923,3893,118495,346498.7 K to 495.3 K (-0.68 %)
Jun 01 2016ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF0.9214,90313,711498,735513.6 K to 498.7 K (-2.90 %)
Jun 01 2016ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOPayment of ExerciseF0.863,5263,032513,638517.2 K to 513.6 K (-0.68 %)
Mar 18 2016ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOBuyP0.7260,00043,200517,164457.2 K to 517.2 K (+13.12 %)
Mar 11 2016ATRSANTARES PHARMA, IN ...APPLE ROBERT FPresident & CEOOption ExerciseA0.88250,000220,000250,000
Jun 01 2015ATRSANTARES PHARMA, IN ...APPLE ROBERT FExecutive Vice Pres ...Option ExerciseA2.18288,786629,553288,786
Jun 01 2015ATRSANTARES PHARMA, IN ...APPLE ROBERT FExecutive Vice Pres ...GrantA0.00142,2940457,164314.9 K to 457.2 K (+45.19 %)
Jun 01 2015ATRSANTARES PHARMA, IN ...APPLE ROBERT FExecutive Vice Pres ...Payment of ExerciseF2.183,3897,388314,870318.3 K to 314.9 K (-1.06 %)
Jun 01 2015ATRSANTARES PHARMA, IN ...APPLE ROBERT FExecutive Vice Pres ...Payment of ExerciseF2.103,5267,405318,259321.8 K to 318.3 K (-1.10 %)
Mar 12 2015ATRSANTARES PHARMA, IN ...APPLE ROBERT FExecutive Vice Pres ...Option ExerciseA2.6295,500250,21095,500

Page:   1